Related Experiment Videos
Calmodulin increases in selective brain regions with opioid dependence
Life Sciences
|November 15, 1982
Summary
Opioid agonists disrupt calcium in thalamic membranes, inhibiting adenylate cyclase. Chronic morphine use increases calmodulin in the thalamus, suggesting molecular adaptations to opioid exposure.
Area of Science:
- Neuropharmacology
- Molecular Biology
- Cellular Signaling
Background:
- Opioid agonists interact with cellular mechanisms in the brain.
- Calcium ions play a critical role in signal transduction pathways.
- Adenylate cyclase activity is a key indicator of cellular response to stimuli.
Purpose of the Study:
- To investigate the acute effects of opioid agonists on thalamic membranes.
- To examine the long-term molecular adaptations in brain regions following chronic morphine administration.
- To determine the role of calmodulin in mediating these changes.
Main Methods:
- Acute challenge of thalamic membranes with opioid agonists.
- Measurement of calcium displacement and adenylate cyclase stimulation.
- Chronic morphine administration (3 days and 3 weeks).
- Quantification of calmodulin levels in various brain regions.
Main Results:
- Opioid agonists acutely displaced calcium and inhibited isoproterenol-stimulated adenylate cyclase in thalamic membranes.
- Chronic morphine administration led to significant calmodulin level increases in thalamic membranes.
- Calmodulin levels remained unchanged in other brain regions including periaqueductal gray, striatum, amygdala, and hypothalamus.
Conclusions:
- Acute opioid receptor activation affects calcium homeostasis and adenylate cyclase signaling in the thalamus.
- Chronic morphine exposure induces region-specific upregulation of calmodulin in the thalamus.
- Calmodulin may be involved in the adaptive mechanisms of the thalamus to prolonged opioid treatment.